Delivery Order SPE2DB25D7056-SPE2DB25FTMRB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, valued at $1,012.15, with an ultimate completion date of October 27, 2025. This competitively awarded contract utilizes firm fixed-price pricing with no set-aside designation and reflects the vendor's role as a critical pharmaceutical supplier to federal military and healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,711.70 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, with completion scheduled for September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,562.33 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, valued at $3,558.49 under a firm fixed-price contract. This delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The pharmaceutical product is...
- The Defense Logistics Agency awarded a $2,395.86 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg under a firm fixed-price contract valued at $2,440.44. The order was competitively awarded without a set-aside designation and is scheduled for completion by October 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is issued under...
- The U.S. Department of Defense, through its Medical Supply Chain organization, awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Escitalopram 10mg tablets in a quantity of 1,000 units. This firm fixed-price delivery order, valued at $3,103.26, represents a non-competitive set-aside award and is scheduled for completion by October 1, 2025. The performance location is AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (90-count units) under a firm fixed-price contract valued at $1,156.44. The award was made on August 15, 2025, with an ultimate completion date of August 18, 2025, and does not include a set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 units) under a firm fixed-price contract valued at $1,740.43. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets in quantities of 1,000 units, valued at $2,255.76 with a firm fixed price structure. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMRBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, valued at $2,124.73. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 26, 2025. The delivery order represents a continuation of AmerisourceBergen's substantial support to the federal medical supply chain, with performance based at the company's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this prime vendor arrangement, the company provides critical medical commodities including specialty medications, generic drugs, and vaccines to customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/25/25 |